Michael L. Etheridge
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Michael L. Etheridge has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- John C. Bischof
University of Minnesota
10 shared publications Bat-Erdene Namsrai
Department of Surgery, University of Minnesota, Minneapolis, USA
4 shared publications- Erik B. Finger
Department of Surgery, University of Minnesota
4 shared publications - Zonghu Han
Department of Mechanical Engineering, University of Minnesota, Minneapolis, USA
3 shared publications - Cameron Scheithauer
Department of Mechanical Engineering, University of Minnesota, Minneapolis, USA
2 shared publications - Casey J. Kraft
Department of Biomedical Engineering, University of Minnesota, USA
2 shared publications
Latest Publications
- Top Cited PapersOpen Access
- 26 September 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-12
Physical vitrification and nanowarming at liter-scale CPA volumes: toward organ cryopreservation
Organ banking via vitrification could transform transplantation, but has never been achieved at human organ scales. This study tested vitrification and rewarming in 0.5–3 L volumes using cryoprotective agents (CPAs): M22, VS55, and 40%EG + 0.6 M Sucrose. Ice formation and cracking was avoided through optimized convective cooling, and successful vitrification was confirmed via visual inspection, thermometry, and X-ray µCT. M22 and EG+sucrose vitrified at 0.5 L, but only M22 succeeded at 3 L; VS55 failed at all volumes. Porcine livers (~0.6–1 L total volume; ~0.23–0.75 L organ volume) were also vitrified using EG+sucrose, though not rewarmed. Future experiments are needed to optimize the protocol and achieve liver rewarming. Using nanowarming with iron-oxide nanoparticles and a newly developed 120 kW RF coil, uniform rewarming was achieved in up to 2 L volumes of M22 at ~88 °C/min. This work serves as a proof-of-concept that human organ scale vitrification and rewarming is physically possible, thereby enabling human organ banking in the future.
- 26 September 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-12
Top Cited PapersOpen AccessPhysical vitrification and nanowarming at liter-scale CPA volumes: toward organ cryopreservation
Organ banking via vitrification could transform transplantation, but has never been achieved at human organ scales. This study tested vitrification and rewarming in 0.5–3 L volumes using cryoprotective agents (CPAs): M22, VS55, and 40%EG + 0.6 M Sucrose. Ice formation and cracking was avoided through optimized convective cooling, and successful vitrification was confirmed via visual inspection, thermometry, and X-ray µCT. M22 and EG+sucrose vitrified at 0.5 L, but only M22 succeeded at 3 L; VS55 failed at all volumes. Porcine livers (~0.6–1 L total volume; ~0.23–0.75 L organ volume) were also vitrified using EG+sucrose, though not rewarmed. Future experiments are needed to optimize the protocol and achieve liver rewarming. Using nanowarming with iron-oxide nanoparticles and a newly developed 120 kW RF coil, uniform rewarming was achieved in up to 2 L volumes of M22 at ~88 °C/min. This work serves as a proof-of-concept that human organ scale vitrification and rewarming is physically possible, thereby enabling human organ banking in the future.
- 14 October 2024
- Published by Elsevier in Cryobiology
- Vol. 117, 104977
Kidney tissue loading reduces the critical cooling and warming rates of VS55 and VMP cryoprotective solutions
- 14 October 2024
- Published by Elsevier in Cryobiology
- Vol. 117, 104977
Kidney tissue loading reduces the critical cooling and warming rates of VS55 and VMP cryoprotective solutions
- 27 December 2023
- Published by Elsevier in Cryobiology
- Vol. 114, 104842
CPA toxicity screening of cryoprotective solutions in rat hearts
- 27 December 2023
- Published by Elsevier in Cryobiology
- Vol. 114, 104842
CPA toxicity screening of cryoprotective solutions in rat hearts
- 7 December 2023
- Published by Elsevier in Cryobiology
- Vol. 113, 104664
A CPA toxicity screening of cryoprotective solutions in rat hearts
- 7 December 2023
- Published by Elsevier in Cryobiology
- Vol. 113, 104664
A CPA toxicity screening of cryoprotective solutions in rat hearts
- Top Cited PapersOpen Access
- 9 June 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-12
Vitrification and nanowarming enable long-term organ cryopreservation and life-sustaining kidney transplantation in a rat model
Banking cryopreserved organs could transform transplantation into a planned procedure that more equitably reaches patients regardless of geographical and time constraints. Previous organ cryopreservation attempts have failed primarily due to ice formation, but a promising alternative is vitrification, or the rapid cooling of organs to a stable, ice-free, glass-like state. However, rewarming of vitrified organs can similarly fail due to ice crystallization if rewarming is too slow or cracking from thermal stress if rewarming is not uniform. Here we use “nanowarming,” which employs alternating magnetic fields to heat nanoparticles within the organ vasculature, to achieve both rapid and uniform warming, after which the nanoparticles are removed by perfusion. We show that vitrified kidneys can be cryogenically stored (up to 100 days) and successfully recovered by nanowarming to allow transplantation and restore life-sustaining full renal function in nephrectomized recipients in a male rat model. Scaling this technology may one day enable organ banking for improved transplantation.
- 9 June 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-12
Top Cited PapersOpen AccessVitrification and nanowarming enable long-term organ cryopreservation and life-sustaining kidney transplantation in a rat model
Banking cryopreserved organs could transform transplantation into a planned procedure that more equitably reaches patients regardless of geographical and time constraints. Previous organ cryopreservation attempts have failed primarily due to ice formation, but a promising alternative is vitrification, or the rapid cooling of organs to a stable, ice-free, glass-like state. However, rewarming of vitrified organs can similarly fail due to ice crystallization if rewarming is too slow or cracking from thermal stress if rewarming is not uniform. Here we use “nanowarming,” which employs alternating magnetic fields to heat nanoparticles within the organ vasculature, to achieve both rapid and uniform warming, after which the nanoparticles are removed by perfusion. We show that vitrified kidneys can be cryogenically stored (up to 100 days) and successfully recovered by nanowarming to allow transplantation and restore life-sustaining full renal function in nephrectomized recipients in a male rat model. Scaling this technology may one day enable organ banking for improved transplantation.
- 10 September 2022
- Published by Springer Nature in Annals of Biomedical Engineering
- Vol. 51 (3) , 538-549
Nerve Protection During Prostate Cryosurgery
Cryosurgery is a minimally invasive approach to the treatment of focal prostate cancer (PCa). A major complication is the cryoinjury to the cavernous nerve in the neurovascular bundle (NVB). This nerve cryoinjury halts conduction of action potentials (APs) and can eventually result in erectile dysfunction and therefore diminished quality of life for the patient. Here, we propose the application of cryoprotective agents (CPA) to the regions of the nerves in the NVB, prior to prostate cryosurgery, to minimize non-recoverable loss of AP conduction. We modeled a cryosurgical procedure based on data taken during a clinical case and applied ex-vivo porcine phrenic nerves and rat sciatic nerve with temperature profile of NVB. The APs were measured before and after the CPA exposures and during 3 h of recovery. Comparisons of AP amplitude recovery with various CPA compositions reveal that certain CPAs (e.g., 5% DMSO + 7.5% Trehalose and 5% M22 for porcine and rat nerves, respectively) showed little or no toxicity and effective cryoprotection from freezing (on average 48% and 30% of recovered AP, respectively). In summary, we demonstrate that neural conduction can be preserved after exposure to freezing conditions if CPAs are properly selected and deployed onto the nerve.
- 10 September 2022
- Published by Springer Nature in Annals of Biomedical Engineering
- Vol. 51 (3) , 538-549
Nerve Protection During Prostate Cryosurgery
Cryosurgery is a minimally invasive approach to the treatment of focal prostate cancer (PCa). A major complication is the cryoinjury to the cavernous nerve in the neurovascular bundle (NVB). This nerve cryoinjury halts conduction of action potentials (APs) and can eventually result in erectile dysfunction and therefore diminished quality of life for the patient. Here, we propose the application of cryoprotective agents (CPA) to the regions of the nerves in the NVB, prior to prostate cryosurgery, to minimize non-recoverable loss of AP conduction. We modeled a cryosurgical procedure based on data taken during a clinical case and applied ex-vivo porcine phrenic nerves and rat sciatic nerve with temperature profile of NVB. The APs were measured before and after the CPA exposures and during 3 h of recovery. Comparisons of AP amplitude recovery with various CPA compositions reveal that certain CPAs (e.g., 5% DMSO + 7.5% Trehalose and 5% M22 for porcine and rat nerves, respectively) showed little or no toxicity and effective cryoprotection from freezing (on average 48% and 30% of recovered AP, respectively). In summary, we demonstrate that neural conduction can be preserved after exposure to freezing conditions if CPAs are properly selected and deployed onto the nerve.
- Open Access
- 28 March 2022
- Published by Wiley in Advanced Therapeutics
- Vol. 5 (5)
Characterization of Miniature Probes for Cryosurgery, Thermal Ablation, and Irreversible Electroporation on Small Animals
Focal therapies, including cryosurgery, thermal ablation, and irreversible electroporation (IRE) are widely used in the treatment of cancer and other diseases, aimed at exposing cancer cells to extreme physical conditions leading to cell death. Focal ablation outcomes are extensively studied in small animal preclinical models, such as mice; however, robust engineering characterization of these treatments is largely lacking, due in a large part to the lack of control in applying clinical devices (cm scale) to mouse tumors (mm scale). To address this issue, miniaturized probes are designed and built for controlled application of cryosurgery, thermal ablation, and IRE and their performance is evaluated using ex vivo porcine liver tissue and an in vivo MC‐38 tumor model. These experimental results are compared to simulated conditions in heat transfer (cryosurgery and thermal ablation) and electrical (IRE) models. Agreements of physical quantities between measurement and modeling are shown for all the focal therapy cases. The in vivo outcome is further correlated with tumor growth delay. The characterization improves the understanding of the energy dose to create tissue damage, therefore enables to better understand outcomes in preclinical studies and predict and optimize the outcome of future clinical procedures.
- 28 March 2022
- Published by Wiley in Advanced Therapeutics
- Vol. 5 (5)
Open AccessCharacterization of Miniature Probes for Cryosurgery, Thermal Ablation, and Irreversible Electroporation on Small Animals
Focal therapies, including cryosurgery, thermal ablation, and irreversible electroporation (IRE) are widely used in the treatment of cancer and other diseases, aimed at exposing cancer cells to extreme physical conditions leading to cell death. Focal ablation outcomes are extensively studied in small animal preclinical models, such as mice; however, robust engineering characterization of these treatments is largely lacking, due in a large part to the lack of control in applying clinical devices (cm scale) to mouse tumors (mm scale). To address this issue, miniaturized probes are designed and built for controlled application of cryosurgery, thermal ablation, and IRE and their performance is evaluated using ex vivo porcine liver tissue and an in vivo MC‐38 tumor model. These experimental results are compared to simulated conditions in heat transfer (cryosurgery and thermal ablation) and electrical (IRE) models. Agreements of physical quantities between measurement and modeling are shown for all the focal therapy cases. The in vivo outcome is further correlated with tumor growth delay. The characterization improves the understanding of the energy dose to create tissue damage, therefore enables to better understand outcomes in preclinical studies and predict and optimize the outcome of future clinical procedures.
- 8 March 2022
- Published by Elsevier in Cryobiology
- Vol. 106, 113-121
Supplemented phase diagrams for vitrification CPA cocktails: DP6, VS55 and M22
- 8 March 2022
- Published by Elsevier in Cryobiology
- Vol. 106, 113-121
Supplemented phase diagrams for vitrification CPA cocktails: DP6, VS55 and M22
- 26 June 2013
- Published by ASME International
Accounting for Aggregation in Heating and Imaging of Magnetic Nanoparticles for Application in Thermal Therapies
Magnetic nanoparticles (mNPs) are known to heat and produce contrast for magnetic resonance imaging (MRI) in response to varying magnetic fields. These phenomena are being clinically applied in the detection and treatment of diseases such as cancer. However, one important factor that has been largely overlooked in the field is the effect of aggregation on the mNPs’ performance once they are delivered into target cells and tissues. Specifically, nanoparticle aggregation caused by protein interactions and cellular uptake can lead to shifts in their behavior due to increases in the interparticle magnetic interactions and changes to Brownian motion. This will affect both the mNPs’ ability to heat and to be imaged by MRI.
- 26 June 2013
- Published by ASME International
Accounting for Aggregation in Heating and Imaging of Magnetic Nanoparticles for Application in Thermal Therapies
Magnetic nanoparticles (mNPs) are known to heat and produce contrast for magnetic resonance imaging (MRI) in response to varying magnetic fields. These phenomena are being clinically applied in the detection and treatment of diseases such as cancer. However, one important factor that has been largely overlooked in the field is the effect of aggregation on the mNPs’ performance once they are delivered into target cells and tissues. Specifically, nanoparticle aggregation caused by protein interactions and cellular uptake can lead to shifts in their behavior due to increases in the interparticle magnetic interactions and changes to Brownian motion. This will affect both the mNPs’ ability to heat and to be imaged by MRI.
- 4 December 2012
- Published by Taylor & Francis
- p. 97-122
Superparamagnetic Iron Oxide Nanoparticle Heating
- 4 December 2012
- Published by Taylor & Francis
- p. 97-122
Superparamagnetic Iron Oxide Nanoparticle Heating